Funding Opportunities
NJ ACTS funding programs accelerate clinical and translational science to develop new therapies and treatments and improve healthcare.
COVID-19 Funding Opportunities
NJ ACTS Funding Opportunities
CTSA Notices and Aministrative Supplements - Fall 2020
Due Date | Title |
---|---|
9/30/2020 |
RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) RFA-OD-20-023 |
11/1/2020 |
CTSA Program: Diversity and Re-Entry Supplements Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) PA-20-022 Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed) PA-18-592 (may be updated soon) NOTE: all administrative supplements are required to be submitted electronically NOT-OD-20-128 CTSA Program-Specific Guidance for Diversity and Re-Entry Research Supplements |
10/1/2020 | Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development NOT-AT-20-010 |
3/5/2021 | Notice of Special Interest: NOSI-OD-21-020 for administrative supplements to support 1) research on bioethical issues to develop or support the development of an evidence base that may inform future policy directions, and/or 2) certain efforts to develop or augment bioethics research capacity. |
7/15/2021 | Notice of Change to Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)” NOT-TR-20-036 |
Additional Funding Sources
Organization | Description |
---|---|
Rutgers Office of Research and Economic Development (ORED) | ORED provides a pipeline of services across Rutgers to drive and support faculty research and strategically leads the university’s economic development activities. |
Rutgers BHI-RUN-NJIT Pilot Grants in Neuroscience Program | A joint effort by Rutgers Brain Health Institute and New Jersey Institute of Technology, that funds interdisciplinary pilot studies to test new ideas in translational neuroscience and obtain preliminary data to allow funding from external sources. |
Charles and Johanna Busch Biomedical Grant Awards | These grants, available to RBHS faculty and their collaborators, are designed to enhance health-related research and strengthen competitive position of faculty members to seek external funds. |
Patient-Centered Outcomes Research Institute (PCORI) | High-quality comparative effectiveness research (CER) projects that will examine a critical patient-centered research question that is also relevant to decision makers and other stakeholders. |
HEAL Initiative: Pain Management Effectiveness Research Network | The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. |
NIH INCLUDE Project | The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) project calls for a new trans-NIH research initiative on critical health and quality-of-life needs for individuals with Down syndrome. |
TechAdvance | Offers grants of up to $100,000 for promising technologies in areas including life science, physical science, engineering, agriculture and IT that have strong potential for commercial success but are “too early” for investors or industry partners. |
Rutgers I-Corps Site | Provides training, resources, networking opportunities, and modest funding to assist in transitioning innovations into the marketplace. Students, faculty, and staff from all Rutgers campuses are eligible to apply. |
NIH Loan Repayment Programs (LRPs) | A set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. |
NHLBI Catalyze Program Current Funding Opportunties | The NHLBI Catalyze Program facilitates the transition of basic science discoveries into viable diagnostic and therapeutic candidates cleared for human testing. |
Citing the CTSA Grant
Please go to the Cite the CTSA page.